Accessibility Menu
 
Lattice Biologics logo

Lattice Biologics

(OTC) LBLTF

Current Price$0.00
Market CapN/A
Since IPO (2016)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Lattice Biologics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$1.56M

Net Income (TTM)

$922.85K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

10.51 (High)

Price

$0.00

Volume

25,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

LBLTF News

No articles available.

LBLTF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lattice Biologics

Industry

Biotechnology

Headquarters

Belgrade, MT 59714, US

LBLTF Financials

Key Financial Metrics (TTM)

Gross Margin

41%

Operating Margin

-14%

Net Income Margin

-60%

Return on Equity

0%

Return on Capital

7%

Return on Assets

-49%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

0

Volume

25.00K

Short Interest

0.00%

Avg. Volume

0

Financials (TTM)

Gross Profit

$1.02M

Operating Income

$336.00K

EBITDA

$58.30K

Operating Cash Flow

$536.15K

Capital Expenditure

$592.08K

Free Cash Flow

$55.93K

Cash & ST Invst.

$57.22K

Total Debt

$3.14M

Lattice Biologics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2021YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$25.85K

+91.9%

EBITDA

$43.06K

+124.1%

Quarterly Fundamentals

Name
Q3 2021YOY CHG

Net Cash

$0.00

+100.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-49.14%

N/A

Return on Invested Capital

6.98%

N/A

Free Cash Flow

$2.13K

+102.3%

Operating Cash Flow

$2.13K

+102.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VRNOFVerano Holdings Corp.
$1.20+7.15%
CLVSFCellaVision AB (publ)
$16.14+0.00%
FDMDF4DMedical Limited
$3.16+0.00%
CALZFPolyNovo Limited
$0.64+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.55-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.00+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$78.50+0.02%
IBITiShares Bitcoin Trust
$39.28-0.02%

Questions About LBLTF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.